Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|December 13, 2005
Antimycotic drug discovery in the age of genomicsJohn D Cleary, Larry A Walker, Roy L Hawke
Current Clinical Pharmacology|August 12, 2008
Warfarin dosing and the promise of pharmacogenomicsTodd E Dumas, Roy L Hawke, Craig R Lee
American Family Physician|August 2, 2017
Common Herbal Dietary Supplement-Drug InteractionsGary N Asher, Amanda H Corbett, Roy L Hawke
Molecules (Basel, Switzerland)|January 19, 2017
Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLDYing Xie, Sonia R Miranda, Janelle M Hoskins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2004
Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytesJeffrey A Sunman, Roy L Hawke, Edward L LeCluyse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2013
Interaction of silymarin flavonolignans with organic anion-transporting polypeptidesKathleen Köck, Ying Xie, Roy L Hawke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2007
Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extractZhiming Wen, Todd E Dumas, Sarah J Schrieber, et al.
Clinical Therapeutics|November 17, 2012
Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extractDina Halegoua-De Marzio, Walter K Kraft, Constantine Daskalakis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2008
Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2)Sonia R Miranda, Jin Kyung Lee, Kim L R Brouwer, et al.
European Journal of Gastroenterology & Hepatology|July 12, 2014
Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potentialJulie C Lauffenburger, Christina L Mayer, Roy L Hawke, et al.
Pageof 3